Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Melendez BD"'
Autor:
Singh S, Xiao Z, Bavisi K, Roszik J, Melendez BD, Wang Z, Cantwell MJ, Davis RE, Lizee G, Hwu P, Neelapu SS, Overwijk WW, Singh M
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2024 Feb 01; Vol. 212 (3), pp. 500.
Autor:
Jackson KR; University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Antunes DA; Department of Biology and Biochemistry, University of Houston, Houston, TX, USA., Talukder AH; Department of Melanoma, UT MD Anderson Cancer Center, Houston, TX, USA., Maleki AR; Department of Melanoma, UT MD Anderson Cancer Center, Houston, TX, USA., Amagai K; Department of Melanoma, UT MD Anderson Cancer Center, Houston, TX, USA., Salmon A; University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Katailiha AS; Department of Melanoma, UT MD Anderson Cancer Center, Houston, TX, USA., Chiu Y; Department of Melanoma, UT MD Anderson Cancer Center, Houston, TX, USA., Fasoulis R; Department of Computer Science, Rice University, Houston, TX, USA., Rigo MM; Department of Computer Science, Rice University, Houston, TX, USA., Abella JR; Department of Computer Science, Rice University, Houston, TX, USA., Melendez BD; University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Li F; Department of Melanoma, UT MD Anderson Cancer Center, Houston, TX, USA., Sun Y; University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Sonnemann HM; University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Belousov V; BostonGene Corporation, Waltham, MA, USA., Frenkel F; BostonGene Corporation, Waltham, MA, USA., Justesen S; Immunitrack Aps, Copenhagen, Denmark., Makaju A; ThermoFisher Scientific, San Jose, CA, USA., Liu Y; ThermoFisher Scientific, San Jose, CA, USA., Horn D; ThermoFisher Scientific, San Jose, CA, USA., Lopez-Ferrer D; ThermoFisher Scientific, San Jose, CA, USA., Huhmer AF; ThermoFisher Scientific, San Jose, CA, USA., Hwu P; Department of Melanoma, UT MD Anderson Cancer Center, Houston, TX, USA., Roszik J; Department of Melanoma, UT MD Anderson Cancer Center, Houston, TX, USA., Hawke D; Department of Systems Biology, UT MD Anderson Cancer Center, Houston, TX, USA., Kavraki LE; Department of Computer Science, Rice University, Houston, TX, USA., Lizée G; Department of Melanoma, UT MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
PNAS nexus [PNAS Nexus] 2022 Jul 27; Vol. 1 (3), pp. pgac124. Date of Electronic Publication: 2022 Jul 27 (Print Publication: 2022).
Autor:
Hailemichael Y; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Johnson DH; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Precision Cancer Therapies Program, Department of Hematology and Medical Oncology, Ochsner Health, New Orleans, LA, USA., Abdel-Wahab N; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Section of Rheumatology & Clinical Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Rheumatology and Rehabilitation, Assiut University Hospitals, Faculty of Medicine, Assiut University, Egypt., Foo WC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bentebibel SE; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daher M; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Haymaker C; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wani K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Saberian C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ogata D; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kim ST; Section of Rheumatology & Clinical Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nurieva R; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, TX, USA., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Abu-Sbeih H; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fa'ak F; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mathew A; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang Y; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Falohun A; Section of Rheumatology & Clinical Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Trinh V; Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zobniw C; Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Spillson C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Burks JK; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Awiwi M; Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Elsayes K; Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Soto LS; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Melendez BD; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wargo J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Curry J; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yee C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lizee G; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Singh S; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sharma P; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Allison JP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ekmekcioglu S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: adiab@mdanderson.org.
Publikováno v:
Cancer cell [Cancer Cell] 2022 May 09; Vol. 40 (5), pp. 509-523.e6. Date of Electronic Publication: 2022 May 09.
Autor:
Singh S; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77054., Xiao Z; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054., Bavisi K; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77054., Roszik J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054., Melendez BD; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77054., Wang Z; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054., Cantwell MJ; Memgen, Inc., Houston, TX 77046; and., Davis RE; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77054., Lizee G; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054., Neelapu SS; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77054., Overwijk WW; Nektar Therapeutics, San Francisco, CA 94158., Singh M; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77054; msingh4@mdanderson.org.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2021 Apr 15; Vol. 206 (8), pp. 1966-1975. Date of Electronic Publication: 2021 Mar 15.
Autor:
Dottino JA; Departments of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Zhang Q; Departments of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Loose DS; Department of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, Houston, TX., Fellman B; Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX., Melendez BD; Departments of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Borthwick MS; Departments of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., McKenzie LJ; Departments of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Yuan Y; Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX., Yang RK; Departments of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Broaddus RR; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC., Lu KH; Departments of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Soliman PT; Departments of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Yates MS; Departments of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: msyates@mdanderson.org.
Publikováno v:
American journal of obstetrics and gynecology [Am J Obstet Gynecol] 2021 Mar; Vol. 224 (3), pp. 278.e1-278.e14. Date of Electronic Publication: 2020 Aug 21.
Autor:
Lyons YA; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pradeep S; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wu SY; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Haemmerle M; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hansen JM; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wagner MJ; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Villar-Prados A; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nagaraja AS; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dood RL; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Previs RA; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hu W; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhao Y; Department of Bioinformatics and Computational Biology, Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mak DH; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xiao Z; Department of Melanoma Medical Oncology-Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Melendez BD; Department of Melanoma Medical Oncology-Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lizee GA; Department of Melanoma Medical Oncology-Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mercado-Uribe I; Department of Pathology, Division of Pathology and Laboratory Medicine, Section of Gynecologic Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Baggerly KA; Department of Bioinformatics and Computational Biology, Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hwu P; Department of Melanoma Medical Oncology-Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu J; Department of Pathology, Division of Pathology and Laboratory Medicine, Section of Gynecologic Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Overwijk WW; Department of Melanoma Medical Oncology-Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Coleman RL; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sood AK; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for RNAi and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Oncotarget [Oncotarget] 2017 Aug 24; Vol. 8 (57), pp. 96496-96505. Date of Electronic Publication: 2017 Aug 24 (Print Publication: 2017).